Picard Medical to go public via merger with Altitude Acquisition Corp.

Picard Medical, parent of SynCardia Systems, entered a definitive business combination agreement with Altitude Acquisition Corp. to become a publicly traded company. The transaction estimates a pre-money enterprise value of $480 million for Picard Medical.

“SynCardia manufactures, sells, and markets the world’s first and only FDA approved and commercially available Total Artificial Heart to replace the full functions of a failing or failed human heart.”altitudeac.com

• 1 source
• altitudeac.comPicard Medical and its Subsidiary, SynCardia Systems, a Pioneer in Total Artificial Heart Technology, to Become a Publicly Traded Company via Merger with Altitude Acquisition Corp. :: Altitude Acquisition Corp. (ALTUU)Apr 24, 2023

Summarized from public sources; check the original articles before acting on it.